Wealth Enhancement Advisory Services, LLC Novo Nordisk A S Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 203,983 shares of NVO stock, worth $10.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
203,983
Previous 228,149
10.59%
Holding current value
$10.2 Million
Previous $15.8 Million
11.13%
% of portfolio
0.03%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding NVO
# of Institutions
1,744Shares Held
337MCall Options Held
10.7MPut Options Held
16M-
Jennison Associates LLC18.9MShares$940 Million0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$736 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$617 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$613 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$591 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $112B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...